^
    Apply
    Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors (NCT05441046)
    Phase 1
    GeneScience Pharmaceuticals Co., Ltd.
    Recruiting
    Last update posted :
    07/06/2022
    Initiation :
    06/07/2022
    Primary completion :
    06/01/2024
    Completion :
    03/01/2025
    IL6 • TNFA • CXCL8 • IL1B • CRP
    |
    Tevimbra (tislelizumab-jsgr) • genakumab (Gensci048)